论文部分内容阅读
在“破征活血药抗癌作用初步观察”一文中,我们曾介绍过丹参可以延长Ehrlich腹水癌小鼠存活期的实验材料。近年来,关于抗凝剂与抗癌药并用能够增强抗癌药效果的资料,及我们观察到的活血化淤药物对病态微循环和高凝状态改善作用,激发了我们探讨丹参、鸡血藤一类活血化淤药对凝血、纤溶过程的影响这一有趣的课题。希望对破征活血药抗癌作用的解释能够有所补充。这项工作是在1978年上半年进行的。
In the article “Preliminary Observation of Anti-cancer Effects of Eliminating Blood Drugs”, we have described experimental materials that Danshen can prolong the survival of mice with Ehrlich ascites. In recent years, the use of anticoagulants and anticancer drugs in combination to enhance the efficacy of anticancer drugs and the effects of the blood circulation and siltation drugs we observed on the improvement of pathological microcirculation and hypercoagulability have stimulated us to explore Salvia Miltiorrhiza and Millettia An interesting topic for the influence of a blood-activating and siltation drug on the coagulation and fibrinolysis process. It is hoped that the explanation for the anti-cancer effect of the anti-cancer drug can be supplemented. This work was carried out in the first half of 1978.